Judge in MDL Actos Litigation Sets More Timelines and Dates in Scheduling Order Issued for Actos Bladder Cancer Lawsuits, the Consumer Justice Foundation Reports

Share Article

The Consumer Justice Foundation, a for-profit corporation whose team of professional consumer advocates provide free online informational resources to the public regarding the potential dangers associated with using certain medications, hereby reports that the presiding judge in the ongoing Actos MDL case has issued a scheduling order that defines timelines for discovery completion and the dates for the first two trials to be held in the case. The CJF’s Web site is located at the URL of http://www.sideeffectsrx.com.

The Consumer Justice Foundation, a for-profit corporation that is dedicated to providing free online educational resources to the public regarding the potential dangers of using certain prescription medication, hereby reports that the judge presiding over the Actos MDL claim has issued a scheduling order that defines several deadlines and the dates for the start of the first two Actos bladder cancer trials.

The Honorable Rebecca Doherty is overseeing the cases in the U.S. District Court for the Western District of Louisiana, and the matter has been assigned a case number of MDL No. 2299. The case is entitled, “In re: Actos (Pioglitazone) Products Liability Litigation" and Judge Doherty issued these specific instructions in a scheduling order that is part of the ongoing case file that includes court documents.

This scheduling order that was issued stated that the first federal Actos bladder cancer lawsuit trial is scheduled to begin on November 3, 2014 with the second trial set for July 8, 2015. In addition, Judge Doherty stated in the scheduling order that the attorneys for plaintiffs and defendants must select the potential trial cases by June 3, 2013 so that a definitive order and roster of parties can be finalized. The parties will have until September 30, 2013 to complete core discovery in these cases.

Judge Doherty stated in the scheduling order that even though these court cases are more than two years from now, the large scope of the litigation, the number of plaintiffs who have already filed Actos bladder cancer claims and the number of additional plaintiffs who could join the litigation that these deadlines need to be met in order for the case to avoid potentially long delays before being adjudicated with a degree of finality.

The plaintiffs in this Actos MDL case who have filed claims all allege that they have used Actos for the purpose of managing their diabetes symptoms and that they have been diagnosed with bladder cancer as a result of the use of this medication. The defendant in this case is Takeda Pharmaceutical, which is the manufacturer of Actos.

About the Consumer Justice Foundation    

The Consumer Justice Foundation, whose Web site can be found at http://www.consumerjusticefoundation.com, is a for-profit organization that serves two purposes for consumers: (1) to provide educational information regarding the policies and procedures of large corporations and how they affect the average consumer; and (2) to provide news updates and resources that continue to update consumers regarding developments taken by corporations that include pharmaceutical drug companies, auto manufacturers and insurance companies so that consumers who have been harmed can use these informational resources to connect to an experienced professional who can help them. The team at the Consumer Justice Foundation is staffed by experienced and passionate consumer advocates whose mission is to raise the awareness of issues that could pose a risk of harm to those who may not otherwise be aware of the dangers they face.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Faith Anderson
Visit website